Regulatory Approvals Required for Certain M&A Deals

Mergers and acquisitions (M&A) can provide substantial growth opportunities and competitive advantages. However, for deals of a certain size or involving specific industries, regulatory approvals are not just a hurdle-they are a legal requirement. Failing to secure the necessary clearances can delay a transaction, expose the parties to fines, or even invalidate the deal entirely. Contact us by either using the online form or calling us directly at 414-253-8500 for legal assistance.

This article outlines the key regulatory frameworks, government agencies, thresholds, and approval processes that parties to an M&A transaction must consider. Understanding these risks upfront can help ensure a smoother transaction and prevent legal complications.

Why Regulatory Approval Matters in M&A

Regulatory approvals exist to prevent anti-competitive behavior, protect national interests, preserve market fairness, and ensure compliance with sector-specific rules. Key objectives include:

Preventing monopolistic control in a given industry.
Safeguarding consumers from price manipulation or decreased product/service quality.
Protecting national security interests, particularly in sectors like defense, technology, and infrastructure.
Ensuring transparency in industries like finance, healthcare, and energy.

Key Regulatory Bodies Involved in M&A Approvals

Several federal and state agencies may be involved in reviewing and approving mergers or acquisitions, depending on the industry, size, and structure of the deal.

1. Federal Trade Commission (FTC) and Department of Justice (DOJ)

These two federal agencies oversee antitrust reviews through the Hart-Scott-Rodino (HSR) Antitrust Improvements Act.

Premerger notification is required for transactions that meet specified thresholds.
The agencies conduct a 30-day initial review, during which they may request additional information (a "second request") if antitrust concerns arise.

2. Committee on Foreign Investment in the United States (CFIUS)

If a transaction involves foreign investment in a U.S. business-especially one that deals with sensitive data, technology, or critical infrastructure-CFIUS review may be required.

Mandatory filings exist for certain sectors (e.g., defense, telecommunications).
Voluntary filings are advisable in high-risk scenarios to avoid post-closing complications or forced divestiture.

3. Federal Communications Commission (FCC)

For deals involving broadcasting, telecommunications, or satellite assets, FCC approval may be required.

FCC reviews focus on public interest and national security.
Ownership limits and foreign investment rules often come into play.

4. State Attorneys General

State-level regulators may also investigate or challenge transactions that impact local competition or consumer protection.

States may act independently or jointly with federal regulators.
Scrutiny may be heightened in sectors like healthcare, insurance, or retail.

Hart-Scott-Rodino (HSR) Act Thresholds and Requirements

The HSR Act is a cornerstone of antitrust enforcement for large transactions. It requires parties to notify the FTC and DOJ before closing, provided certain monetary thresholds are met.

2025 HSR Thresholds (Adjusted Annually)

Size-of-transaction test: Generally triggered if the transaction is valued at $119.5 million or more.
Size-of-person test: Applies if one party has sales/assets of $239 million and the other $23.9 million or more.

If both thresholds are met, the parties must:

File a Premerger Notification and Report Form.
Pay a filing fee, which scales based on deal size.
Observe a waiting period (typically 30 days, unless extended by a second request).

Failure to comply can result in civil penalties up to $51,744 per day.

Foreign Investment Scrutiny and CFIUS Review

CFIUS plays a significant role in transactions involving foreign buyers or cross-border M&A. Its jurisdiction has expanded in recent years under the Foreign Investment Risk Review Modernization Act (FIRRMA).

Key CFIUS Considerations:

Transactions involving sensitive personal data, emerging technologies, or critical infrastructure are most at risk.
Non-compliance could lead to unwinding of the transaction or forced divestiture post-closing.
CFIUS reviews typically take 30-45 days, with an optional 45-day investigation phase.

Pro Tip: Even if not mandated, filing a voluntary notice can offer strategic protection.

Industry-Specific Regulatory Approvals

Some industries are subject to additional layers of review due to their economic or social impact.

Banking and Financial Services

Regulatory approvals from the Federal Reserve, FDIC, and OCC may be needed.
Change-in-control applications are required for transactions involving significant ownership transfers.

Healthcare

The Centers for Medicare and Medicaid Services (CMS) and state health departments may review mergers involving hospitals or providers.
Antitrust scrutiny is high due to the potential for cost increases.

Energy

The Federal Energy Regulatory Commission (FERC) regulates energy-related M&A.
Mergers involving natural gas, electric utilities, or hydropower must demonstrate public benefit.

Timing, Strategy, and Deal Structuring for Regulatory Compliance

Proper timing and strategy are critical when planning a merger or acquisition that requires regulatory approval. From initial letter of intent to closing, parties must anticipate how regulatory requirements may influence timelines and deal terms.

Key Strategic Considerations:

Early Risk Assessment: Conduct a regulatory risk audit during the due diligence phase to identify red flags such as antitrust exposure, data privacy issues, or sector-specific licensing obligations.
Staggered Closings or Conditional Agreements: Deal structures may include conditions precedent related to regulatory approval. Parties can agree to close certain aspects of the deal while awaiting approvals for others.
Reverse Termination Fees: In cross-border or high-risk transactions, buyers may agree to pay a reverse breakup fee if they cannot secure regulatory clearance-especially in deals subject to CFIUS or international competition law.
Clean Teams and Firewalls: When competitors merge, clean teams can be used to protect competitively sensitive information during pre-closing integration planning without violating antitrust laws.

Consequences of Failing to Obtain Regulatory Approval

Ignoring or mismanaging regulatory obligations can derail an entire transaction. Consequences may include:

Civil penalties for failure to file HSR notifications.
Injunctions or litigation from the FTC, DOJ, or state AGs.
Forced divestitures or restructuring of the deal.
Loss of licenses or government contracts if proper agency approval is not obtained.
Reputational harm to the parties involved, particularly if sensitive data or foreign ownership issues are mishandled.

International Regulatory Approvals

For multinational deals, compliance doesn't end at U.S. borders. Many jurisdictions have merger control laws, and approval may be required from international authorities such as:

European Commission (EC)
Competition Bureau (Canada)
SAMR (China)
Japan Fair Trade Commission (JFTC)

Delays in these jurisdictions can stall or derail global transactions, even if U.S. clearance is granted.

Coordinating Multijurisdictional Filings

When transactions touch multiple regulatory frameworks, it's critical to coordinate filings and ensure harmonized disclosures. Experienced legal counsel can help manage:

Global filing calendars
Strategic jurisdictional sequencing
Communication with competition authorities
Managing confidentiality across filings

How Legal Counsel Can Help in the Regulatory Process

M&A lawyers play a crucial role in navigating the regulatory environment and protecting your interests. At Heritage Law Office, we help clients:

Conduct regulatory due diligence and compliance reviews.
Draft and negotiate deal terms that address regulatory risks.
Prepare premerger notifications and agency filings.
Respond to agency inquiries, including second requests or CFIUS investigations.
Coordinate multijurisdictional approvals in complex, cross-border transactions.

Even if your deal doesn't appear to raise regulatory flags, engaging counsel early helps ensure that no approval is overlooked-and no liability is incurred.

Contact an Attorney for M&A Regulatory Review

If you're contemplating a merger, acquisition, or business consolidation, securing the proper regulatory approvals is essential for a successful closing. The experienced attorneys at Heritage Law Office can help ensure compliance with federal, state, and industry-specific requirements, while minimizing disruption to your timeline.

Contact us today at 414-253-8500 or by visiting our contact page to schedule a consultation.

Frequently Asked Questions (FAQs)

1. What triggers a mandatory antitrust filing under the Hart-Scott-Rodino Act?

A mandatory antitrust filing is triggered when an M&A transaction meets or exceeds the HSR thresholds, which are updated annually. For 2025, this generally applies if the deal is valued at $119.5 million or more, and the parties meet the size-of-person criteria. Even transactions below this level may require filing if they involve assets or voting securities exceeding the threshold and raise competitive concerns.

2. Do small business acquisitions require regulatory approval?

In most cases, small business acquisitions do not require federal regulatory approval unless the transaction involves certain regulated industries (e.g., healthcare, banking) or if the acquirer is a foreign entity investing in a U.S. business with national security implications. However, state-level approvals or license transfers may still apply.

3. What is a "second request" in an antitrust review?

A "second request" is an in-depth investigation initiated by the FTC or DOJ during the HSR waiting period. It involves a formal demand for additional documents, data, and information to assess potential anticompetitive effects of the transaction. A second request can significantly delay closing, sometimes by several months.

4. Can a transaction close before regulatory approval is obtained?

Generally, no-transactions subject to the HSR Act or other regulatory frameworks must wait for clearance or expiration of the waiting period before closing. "Gun-jumping," or acting as a single entity before approval, can lead to fines and enforcement actions. However, some deals may be structured with contingencies or staggered closings, provided all legal requirements are met.

5. What industries are most likely to face heightened regulatory scrutiny during M&A?

Industries subject to intense regulatory scrutiny during M&A include:

Healthcare
Banking and financial services
Telecommunications
Defense and aerospace
Energy and utilities
Technology and data-driven sectors

These sectors often have overlapping oversight from multiple agencies due to consumer impact, national security, or economic influence.